RBM44

Across TCGA pan-cancer cohorts, RBM44 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RBM44’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RBM44 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBM44 is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.

HNSC, LIHC, and KICH are the cancer types where RBM44 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM44 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.136	<.001	7	view →
LIHC	All	All	+0.060	<.001	7	view →
KICH	All	All	−0.162	<.001	6	view →
BRCA	Female	All	−0.131	.001	6	view →
LUAD	Female	II,III,IV	−0.307	.002	5	view →
THCA	All	All	−0.080	.001	5	view →
KIRC	All	All	+0.079	<.001	5	view →
LUSC	All	II,III,IV	−0.231	.002	4	view →
CHOL	All	All	+0.245	.006	2	view →
STAD	All	II,III,IV	+0.190	.017	2	view →
KIRP	Male	All	−0.090	.016	2	view →
COAD	All	II,III,IV	+0.077	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RBM44–HNSC

Open the HNSC breakdown →